Welcome to our dedicated page for Wrap Technologies SEC filings (Ticker: WRAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Wrap Technologies, Inc. (Nasdaq: WRAP) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-assisted summaries to help interpret complex documents. As a Delaware corporation in the non-lethal public safety technology and manufacturing space, Wrap files a range of forms that shed light on its capital structure, governance, and strategic initiatives around products such as the BolaWrap 150, WrapReality VR, WrapVision body-worn camera system, WrapTactics training programs, and CUAS solutions like PAN-DA and MERLIN-Interdictor.
Through Forms 10-K and 10-Q, investors can review Wrap’s audited and quarterly financial statements, risk factors, and management discussion of its non-lethal response ecosystem, subscription offerings like WrapReady and WrapPlus, and investments in research and development. Current reports on Form 8-K detail material events, including private placements of Series B Convertible Preferred Stock and accompanying warrants, amendments to the Amended and Restated Certificate of Incorporation to increase authorized common shares, changes to bylaws governing stockholder voting standards, executive transitions, and updates on equity compensation plans.
Proxy materials such as the DEF 14A definitive proxy statement provide information on board elections, share authorization proposals, reverse stock split authority, and incentive plan amendments. These documents outline how the company seeks stockholder approval for actions that affect existing and potential WRAP shareholders.
On Stock Titan, AI-powered tools highlight key points from lengthy filings, explain technical terms, and surface items related to equity issuance, voting rights, and compensation plans. Users can quickly identify disclosures about preferred stock designations, warrant terms, registration rights agreements, and other capital markets activities. The filings page also links to any reported insider-related information contained in these documents, helping investors understand how governance and financing decisions intersect with Wrap’s strategy in non-lethal public safety, training, and counter-UAS technologies.
Wrap Technologies director Bruce Bernstein reported a new stock option grant. On February 1, 2026, he received a stock option to buy 100,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.
According to the filing, 33,000 options vested immediately on the grant date. The remaining options will vest in three equal annual tranches, as long as Bernstein continues to be employed by or provide services to the company on each vesting date. After this grant, he beneficially owns 100,000 derivative securities directly.
Juggernaut Management, LLC, an entity associated with WRAP director John D. Shulman, acquired 250,000 shares of common stock at $2.00 per share and 250,000 warrants with a $2.30 exercise price in a private placement on February 2, 2026.
The warrants can be exercised into 250,000 WRAP common shares and their exercise price is adjustable if the company issues stock or convertible securities below $2.30. Following these transactions, Shulman also directly owned 79,394 WRAP common shares.
Wrap Technologies director Marc Savas reported new indirect and direct holdings in the company’s stock. Savbo Investments LLC, of which he is Chief Executive Officer, acquired 25,000 shares of common stock from Wrap Technologies at $2 per share in a private placement under a Securities Purchase Agreement dated February 2, 2026.
Savbo Investments LLC also acquired 25,000 PIPE warrants with an exercise price of $2.30 per share, exercisable from February 3, 2026 until February 3, 2031, with the exercise price subject to adjustment if certain lower-priced issuances occur. Following these transactions, Savas indirectly owns 75,000 shares through Savbo Investments LLC and directly owns 223,213 shares of Wrap Technologies common stock.
Wrap Technologies director Rajiv Srinivasan reported a new stock option grant. On February 1, 2026, he received a stock option to buy 50,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.
According to the filing, 16,500 options vested on the grant date, and the remaining options will vest ratably in three annual tranches thereafter, provided that he is employed or providing services to the company on each vesting date. After this grant, he beneficially owns 50,000 derivative securities directly.
Wrap Technologies insider activity: A family trust associated with 10% owner Elwood G. Norris reported two open-market sales of WRAP common stock. On January 28, 2026, the trust sold 68,020 shares at a weighted average price of $2.4619, and on January 29, 2026 it sold 80,000 shares at a weighted average price of $2.207. The prices reflect multiple trades in ranges from $2.44–$2.52 and $2.14–$2.26, respectively. After these transactions, the trust indirectly held 5,303,033 WRAP shares.
Wrap Technologies 10% owner Elwood G. Norris reported sustained open-market stock sales over several months in 2025. The Form 4 shows multiple sales of Wrap Technologies common stock between June 13, 2025, and November 28, 2025, at prices generally ranging from about $1.50 to $2.91 per share, often reported as weighted-average prices across numerous trades.
After the latest reported sale of 5,000 shares at $2.153 on November 28, 2025, Norris directly held 54,928 shares. Earlier, on June 13, 2025, he directly held 859,339 shares. In addition to his direct holdings, he is shown as indirectly beneficially owning 5,451,053 shares of common stock through a family trust.
Wrap Technologies, Inc. shareholders Elwood G. Norris, Stephanie A. Norris and the Norris Family 1997 Trust filed Amendment No. 4 to update their Schedule 13D on the company’s common stock.
Elwood G. Norris reports beneficial ownership of 5,505,981 shares, representing 10.7% of the outstanding common stock, including 5,451,053 shares held through the Norris Family 1997 Trust. Stephanie A. Norris and the Trust each report beneficial ownership of 5,451,053 shares, or 10.6% of the class, with shared voting and dispositive power over those shares.
The amendment also discloses that the reporting persons filed Form 144 notices on May 6, 2025, October 6, 2025, and January 23, 2026, stating their intent to sell up to 505,542, 794,455, and 1,778,129 shares, respectively, from time to time in brokers’ transactions under Rule 144.
Elwood G Norris filed a notice to sell up to 1,778,173 shares of WRAP common stock, with an aggregate market value of $4,445,432, through broker Charles Schwab on Nasdaq around 01/23/2026. The filing lists 51,549,094 shares of WRAP common stock outstanding.
The shares to be sold were acquired directly from the issuer, including 333,334 shares purchased for cash on 10/30/2018 and 1,444,839 shares obtained via warrant exercise for cash on 06/01/2020. The notice also details prior WRAP common stock sales by Norris during the past three months, such as 55,000 shares sold on 10/31/2025 for $154,974 and multiple additional sales in October and November 2025.
Wrap Technologies, Inc. director Marc Savas reported an equity award linked to the company’s common stock on January 12, 2026. The transaction covers 7,063 shares at a stated price of $0.00, reflecting a grant rather than an open-market purchase. According to the footnote, this represents a grant of Restricted Stock Units, with 2,119 RSUs vesting on the grant date and the remaining units vesting in eleven equal monthly installments. After this award, Savas is shown as beneficially owning 223,213 shares of Wrap Technologies common stock directly.
WRAP Technologies director Rajiv Srinivasan reported an equity award of 3,346 shares of common stock through a grant of restricted stock units (RSUs). The award was recorded at a price of $0 per share, reflecting that it is a compensatory grant rather than an open‑market purchase.
According to the terms, 1,004 of the RSUs vested on the January 12, 2026 grant date, and the remaining units vest in eleven equal monthly tranches. After this grant, Srinivasan beneficially owns 145,107 shares of WRAP common stock directly.